Argyrophilic glial inclusions in the midbrain of patients with Parkinson's disease and diffuse Lewy body disease are immunopositive for NACP/α-synuclein
- 8 January 1999
- journal article
- Published by Elsevier in Neuroscience Letters
- Vol. 259 (2), 83-86
- https://doi.org/10.1016/s0304-3940(98)00890-8
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Human recombinant NACP/α-synuclein is aggregated and fibrillated in vitro: Relevance for Lewy body diseaseBrain Research, 1998
- α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson’s disease and dementia with Lewy bodiesProceedings of the National Academy of Sciences, 1998
- Changes in presynaptic protein NACP/α-synuclein in an ischemic gerbil hippocampusBrain Research, 1998
- AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's diseaseNature Genetics, 1998
- Mutation in the α-Synuclein Gene Identified in Families with Parkinson's DiseaseScience, 1997
- Glial tau-positive structures lack the sequence encoded by exon 3 of the tau protein geneNeuroscience Letters, 1997
- Gallyas-positive, tau-negative glial inclusions in Parkinson's disease midbrainNeuroscience Letters, 1996
- Microglia in the immune surveillance of the brain: Human microglia constitutively express HLA-DR moleculesJournal of Neuroimmunology, 1993
- Complement-activated oligodendroglia: A new pathogenic entity identified by immunostaining with antibodies to human complement proteins C3d and C4dNeuroscience Letters, 1990
- Transferrin, carbonic anhydrase C and ferritin in dissociated murine brain cell culturesJournal of Neuroimmunology, 1988